Next Article in Journal
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age
Next Article in Special Issue
Development of Plant-Based Multivalent Vaccine Candidates for SARS-CoV-2 and Influenza Virus Using Inactivated Lactococcus
Previous Article in Journal
Long-Term Protection in Atlantic Salmon (Salmo salar) to Pancreas Disease (PD) Can Be Achieved Through Immunization with Genetically Modified, Live Attenuated Salmonid Alphavirus 3
 
 
Review

Article Versions Notes

Vaccines 2025, 13(2), 191; https://doi.org/10.3390/vaccines13020191
Action Date Notes Link
article xml file uploaded 15 February 2025 08:00 CET Original file -
article xml uploaded. 15 February 2025 08:00 CET Update https://www.mdpi.com/2076-393X/13/2/191/xml
article pdf uploaded. 15 February 2025 08:00 CET Version of Record https://www.mdpi.com/2076-393X/13/2/191/pdf
article html file updated 15 February 2025 08:03 CET Original file https://www.mdpi.com/2076-393X/13/2/191/html
Back to TopTop